Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management

0545157 - ÚŽFG 2022 RIV GB eng J - Článek v odborném periodiku
Tiwari, A. P. - Thorat, N. D. - Pricl, S. - Patil, M. R. - Rohiwal, Sonali Suresh - Townley, H.
Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management.
Drug Discovery Today. Roč. 26, č. 7 (2021), s. 1574-1590. ISSN 1359-6446. E-ISSN 1878-5832
Institucionální podpora: RVO:67985904
Klíčová slova: bioinks * 3D bioprinting technologies
Obor OECD: Health-related biotechnology
Impakt faktor: 8.369, rok: 2021
Způsob publikování: Omezený přístup
https://asep.lib.cas.cz/arl-cav/cs/csg/?repo=crepo1&key=49068867803

'Bioinks' are important tools for the fabrication of artificial living-tissue constructs that are able to mimic all properties of native tissues via 3D bioprinting technologies. Bioinks are most commonly made by incorporating live cells of interest within a natural or synthetic biocompatible polymeric matrix. In oncology research, the ability to recreate a tumor microenvironment (TME) using by 3D bioprinting constitutes a promising approach for drug development, screening, and in vitro cancer modeling. Here, we review the different types of bioink used for 3D bioprinting, with a focus on its application in cancer management. In addition, we consider the fabrication of bioink using customized materials/cells and their properties in the field of cancer drug discovery.
Trvalý link: http://hdl.handle.net/11104/0321909